KMT2A and nonpapillary renal cell carcinoma: The link shown by COSMOS between KMT2A and adenosine is interesting, because KMT2A mutations have been reported in a number of ccRCC patients (Yan et al, 2019), suggesting that this enzyme might play a functional role in ccRCC development.